Skip to content

Tibia bone related fracture fixation study

Post Marketing Clinical Follow-up Study, a single arm prospective case series to evaluate the safety and effectiveness of Intramedullary Tibia Nailing system intended for Tibia bone related fracture fixation (PMCF-INITIA NAIL) - PMCF-INITIA NAIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046936
Enrollment
35
Registered
2022-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V00-Y99- External causes of morbidity

Interventions

Intervention1: Tibia Nailing System: Intended for fracture fixation of Tibia bone
Single use device for more than 30 days Control Intervention1: NA: NA

Sponsors

Kaulmed Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject is willing and able to give informed consent for participation in the study 2. Male or Female, aged 18 years or above, skeletally mature patient. 3. Subject is willing and able to complete required study visits or assessments. 4. Subject diagnosed as per indications.

Exclusion criteria

Exclusion criteria: 1. Subjects with a disease entity or condition that could hindered bone healing and create unacceptable risk of fixation failure or complications such as known active cancer, neuromuscular disorder etc. 2. In case in subject has inadequate tissue coverage of the operative site. (Open fracture, Gustilo type IIIC) 3. Subjects unwilling to sign the Informed Consent document. 4. Subjects who are incarcerated or have pending incarceration. 5. Female participant who is pregnant or planning pregnancy during the course of the study. 6. Fracture that are not amenable to intramedullary tibia nailing technique 7. Morbid obesity (BMI (Kg/m2)) > 35

Design outcomes

Primary

MeasureTime frame
Evaluation of functional performance from baseline to last follow up by recording the Lower extremity functional score (LEFS).Timepoint: Visit - Screening, 1, 2, 3, 4

Secondary

MeasureTime frame
Assessment Quality of Life (QOL) by SF-12Timepoint: Screening, 1, 2, 3, 4;Duration of Hospital stay, Revision rate (Removal of any Component), Re-operation Rate.Timepoint: 12 Months;Evaluation of Safety of Device by record of any adverse event, serious adverse event and complication during follow up, especially the one mentioned in the Instruction of Use. (IFU)Timepoint: Visit - Pre-surgery, Post-surgery, 1, 2, 3, 4;Follow-up of the patient’s recovery by a analysing Visual analogue score (VAS) for pain assessment.Timepoint: Visit - Screening, Pre-surgery, Post-surgery, 1, 2, 3, 4;Mortality.Timepoint: 12 months;Radiologic Evaluation (X-Ray)Timepoint: Screening, Pre-surgery, Post-surgery, 1,2,3,4

Countries

India

Contacts

Public ContactGaurav Luthra

Kaulmed Private Limited

lokesh.chauhan@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026